• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Higher maternal prenatal weight may adversely influence offspring cognition and behaviour

byYuchen DaiandMichael Pratte
August 24, 2021
in Chronic Disease, Obstetrics, Pediatrics
Reading Time: 3 mins read
Diffusion tensor imaging valuable in the evaluation of peripheral neuropathy
Share on FacebookShare on Twitter

1. In this cohort study, higher maternal prenatal body mass index was associated with worse neurocognitive development in offspring.

2. Children born to women with higher maternal weight status should be followed closely for neurodevelopmental and behavioral concerns and referred appropriately for early intervention and support.

Evidence Rating Level: 2 (Good)

Study Rundown: There are a host of early childhood exposures associated with fetal brain development as well as childhood cognition and behavior, including environmental insults/toxicants, psychosocial stress, and infant nutrition. Due to the recent rise in the global prevalence of obesity, including in women of child-bearing age, the long-term effects of maternal prenatal weight status on offspring cognition and behavior have become an area of particular interest. This cohort study, using data from a breastfeeding intervention trial in Belarus, sought to evaluate associations between maternal prenatal body mass index (BMI) and cognition and behavior of offspring born full-term in a setting where the overall prevalence of maternal and child obesity was low. The main endpoints of the analysis were 1) offspring cognition assessed by pediatricians using the Wechsler Abbreviated Scales of Intelligence (WASI) at 6.5 years and the computerized self-administered NeuroTrax battery at 16 years (both with an approximate mean [SD] of 100 [15]), and 2) child behavior rated by parents and teachers using the Strengths and Difficulties Questionnaire (SDQ, range 0-40) at 6.5 years. Among 11,276 children included in the study, higher maternal BMI after 35 weeks’ gestation was associated with a slightly lower offspring intelligence quotient at 6.5 years and lower cognitive scores in multiple domains at 16 years. Associations adjusted for baseline sociodemographic characteristics as well as pregnancy complications and paternal weight and were not mediated by child weight. These findings suggested that children born to women with higher maternal BMI should be followed closely for neurodevelopmental and behavioral concerns and referred appropriately for early intervention and support. Additional longitudinal research looking into the mechanisms and negative synergistic effects by which environmental exposures, such as maternal prenatal weight and nutritional status can affect fetal brain development, is needed. A limitation of this study was that all participants were Belarusian, where the overall rates of obesity were low in the region and thus, diminishing the generalizability of the study’s findings.

Click to read the study in JAMA

Relevant Reading: PROBIT Study Group (Promotion of Breastfeeding Intervention Trial). Promotion of Breastfeeding Intervention Trial (PROBIT): a randomized trial in the Republic of Belarus

RELATED REPORTS

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

In-Depth [retrospective cohort]: This cohort study, PROBIT, included 11,276 patients (9,355 [83%] women aged 20 to 34 years, 10,128 (89.8%) married, 11,050 (98.0%) non-smokers during pregnancy) from a breastfeeding promotion intervention at 31 centers in Belarus. Offspring cognition and behavior were longitudinally assessed from birth (1996-1997) to adolescence (2017-2019) and compared with maternal BMI data from prenatal medical records. Primary exposure included maternal BMI, calculated as weight in kilograms divided by height in meters squared after 35 weeks’ gestation. Overall, each 5-unit increase in maternal BMI during pregnancy (mean [SD], 27.2 [3.8]) was associated with lower childhood WASI performance (-0.52 points; 95%CI, -0.87 to -0.17 points) at 6.5 years and lower scores on 5 of 7 NeuroTrax subscales and the global cognitive score at 16 years (-0.67 points; 95%CI, -1.06 to -0.29 points), with similar results after adjusting for sociodemographic characteristics. Furthermore, higher maternal BMI during pregnancy was associated with more teacher-reported behavioral problems via SDQ but not parent-reported behavioral problems (externalizing behaviors: 0.13 points; 95%CI, 0.02 to 0.24 points; total difficulties: 0.14 points, 95%CI, -0.02 to 0.30 points), with similar results for maternal BMI measured in the first trimester or postpartum. Conversely, higher 6.5-year paternal BMI was associated with improved child cognition (WASI verbal IQ: 0.42 points; 95%CI, 0.02 to 0.82 points; NeuroTrax executive function score: 0.68 points; 95%CI, 0.24 to 1.12 points) and fewer teacher-reported behavioral problems (total difficulties: -0.29 points; 95%CI, -0.46 to -0.11 points).

Image: PD

©2021 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: behaviorbehavioral healthneurocognitive developmentobesity
Previous Post

Prescription tranquilizer and sedative misuse motives vary widely amongst United States of America population

Next Post

Once weekly tirzepatide is superior to daily insulin degludec for treatment of uncontrolled type 2 diabetes

RelatedReports

Artificial Intelligence

Universal Health Services acquisition of Talkspace connects virtual and inpatient behavioral care

September 9, 2026
Collage of medical tech icons circling a central chip with 'AI Roundup' title and 2 Minute Medicine logo in teal background.
AI Roundup

2MM: AI Roundup: FDA clears autonomous blood draw robot, UHS acquires Talkspace, Databricks reaches $190 billion valuation, and AI-designed glioblastoma vaccine advances

September 8, 2026
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Pharma

Glucagon-like peptide-1 receptor agonists show potential in reducing substance use disorders

May 7, 2026
Many new pediatric asthma cases attributable to obesity
Cardiology

150 minutes of moderate-to-vigorous physical activity per week may reduce cardiovascular risk in overweight or obese adults

February 26, 2026
Next Post
Pediatric DKA associated with recent acute care visits

Once weekly tirzepatide is superior to daily insulin degludec for treatment of uncontrolled type 2 diabetes

Compliance-linked incentives increase infant immunizations rates in rural India

High-dose Hepatitis B revaccination schedule improves serological response among patients with Human Immunodeficiency Virus

Prescription of antibiotics for acute respiratory infections increasing

Association of age and pediatric household transmission of SARS-CoV-2 infection

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.